SDS.WAR SDS Optic S.A.
- Market cap
- PLN 22.2M
- P/E
- -
- P/B
- 17.74x
- ROE
- -259.6%
- Dividend yield
- -
- Fundamental score
- 0.4/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is SDS.WAR undervalued?
Graham numberThe Graham number of SDS Optic S.A. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SDS Optic S.A. fundamental analysis
2 of 21 checks passedROE 0/2
Low return on equity (-259.6%), below 10%.
ROA 0/1
Return on assets (-19.8%) is below the industry median (-18.6%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (48.0%) is above the industry median (2.6%).
Revenue Growth 0/2
Revenue shrank 3.9% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash covers 0.2 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (17.8x) is above the industry median (3.6x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
SDS Optic S.A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SDS Optic S.A.
SDS Optic Spolka Akcyjna discovers, develops, produces, and commercializes diagnostics and monitoring tools worldwide. It offers inPROBE, a cancer diagnostics and treatment device that measure the level of active ingredients in cancer tumor cells. The company is also involved in the modeling and designing of package components, such as ferrules, housings, and other devices with flat and conical surface areas. In addition, it provides contract chemistry, molecular biology, mu…
Full company profileSDS Optic S.A. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SDS Optic S.A. annual financial statements (PLN; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 849K | 3.35K | 0.00 | 753K | 607K |
| Gross Profit | -1.79M | 2.51M | 4.78M | 2.76M | 901K |
| Operating Income | -3.33M | -3.91M | -4.07M | -2.04M | -1.88M |
| EBITDA | -3.62M | -3.22M | -3.81M | -1.14M | -1.69M |
| Net Income | -3.94M | -3.48M | -5.05M | -2.79M | -3.40M |
| EPS | -0.74 | -0.59 | -0.85 | -0.44 | -0.51 |
| Balance Sheet | |||||
| Total Assets | 7.95M | 9.44M | 17.5M | 16.7M | 17.1M |
| Total Liabilities | 1.45M | 830K | 14.0M | 15.1M | 15.8M |
| Shareholders' Equity | 6.41M | 8.61M | 3.51M | 1.57M | 1.31M |
| Cash & Short-term Investments | 952K | 1.28M | 3.06M | 1.08M | 1,000K |
| Cash Flow | |||||
| Operating Cash Flow | -9.68M | -10.0M | -8.37M | -7.08M | -6.03M |
| Capital Expenditure | 2.91M | 422K | 2.94M | 353K | 0.00 |
| Free Cash Flow | -12.6M | -10.4M | -11.3M | -7.44M | -6.03M |
| Ratios | |||||
| ROE | -61.5% | -40.4% | -143.8% | -177.8% | -259.6% |
| ROA | -49.5% | -36.9% | -28.8% | -16.7% | -19.8% |
| Net Profit Margin | -463.8% | -103,938.7% | - | -370.2% | -559.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
SDS Optic S.A. dividends
SDS Optic S.A. has not paid dividends in the last 4 fiscal years.
Who owns SDS Optic S.A.
- Insiders 49.81%
- Institutions 2.35%
- Public & others 47.84%
- Shares outstanding 6.68M
SDS Optic S.A. company profile
- Company name
- SDS Optic S.A.
- Ticker
- SDS.WAR
- ISIN
- PLSDSOP00013
- Exchange
- Warsaw Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- December
- Address
- Centrum ECOTECH-COMPLEX, Lublin, Poland, 20-612
- Phone
- 48 81 501 9463
- Website
- sdsoptic.pl
About SDS Optic S.A.
SDS Optic Spolka Akcyjna discovers, develops, produces, and commercializes diagnostics and monitoring tools worldwide. It offers inPROBE, a cancer diagnostics and treatment device that measure the level of active ingredients in cancer tumor cells. The company is also involved in the modeling and designing of package components, such as ferrules, housings, and other devices with flat and conical surface areas. In addition, it provides contract chemistry, molecular biology, multidisciplinary in vivo diagnostics and monitoring solutions development, comparative studies of biosimilar products, and early-stage in vivo and in vitro diagnostic technologies scale-up and commercialization services, as well as undertakes integrated multiple key-steps pre-clinical discovery projects. The company was founded in 2013 and is based in Lublin, Poland.
SDS Optic S.A. management
3- Mr. Marcin StaniszewskiChief Executive Officer
- Ms. Marta GecaFinancial Controller
- Ms. Magdalena Staniszewska Ph.D.Chief Scientific Officer